Tandem Diabetes Care Inc (TNDM)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$22.25
Buy
$23.00
$-0.15 (-0.66%)
Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application.
Prices updated at 15 May 2025, 21:42 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
| Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
|---|---|---|---|---|---|
| 2024 | 52.07 | -10.54 | -10.21 | -7.42 | -70m |
| 2023 | 49.18 | -31.19 | -29.77 | -26.27 | -196m |
| 2022 | 51.54 | -11.59 | -11.81 | -9.26 | -74m |
| 2021 | 53.53 | 3.22 | 2.21 | 4.85 | 34m |
| 2020 | 52.23 | -1.60 | -6.89 | -2.74 | -14m |
| 2019 | 53.60 | -4.62 | -6.83 | -5.11 | -19m |
| 2018 | 48.85 | -24.27 | -66.68 | -59.38 | -109m |
| 2017 | 40.98 | -58.50 | -67.87 | -50.95 | -55m |
| 2016 | 28.00 | -92.64 | -99.05 | -85.78 | -72m |
Valuation data table
| Year | Price / Sales | Price earnings | Price / Cash flow |
|---|---|---|---|
| 2025 | 1.53 | - | 107.70 |
| 2024 | 2.75 | - | 373.87 |
| 2023 | 2.48 | - | - |
| 2022 | 3.65 | - | 44.93 |
| 2021 | 14.51 | 418.11 | 89.66 |
| 2020 | 13.12 | - | 199.59 |
| 2019 | 10.49 | - | 94.61 |
| 2018 | 9.26 | - | - |
| 2017 | 0.10 | - | - |
| 2016 | 0.77 | - | - |
| 2015 | 5.23 | - | - |
Price/Forward earnings (YTD)
-16.45
Returns
Debt profile
Returns data table
| Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
|---|---|---|---|
| 2024 | -10.00 | -33.30 | -14.45 |
| 2023 | -22.20 | -59.08 | -29.49 |
| 2022 | -9.66 | -21.67 | -11.94 |
| 2021 | 1.92 | 3.89 | 2.85 |
| 2020 | -6.60 | -12.25 | -6.01 |
| 2019 | -9.30 | -15.17 | -15.35 |
| 2018 | -81.30 | -240.11 | -132.25 |
| 2017 | -70.31 | - | - |
| 2016 | -70.38 | -290.04 | -94.15 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 3.68 |
| 2023 | 3.04 |
| 2022 | 2.39 |
| 2021 | 2.09 |
| 2020 | 1.96 |
| 2019 | 1.67 |
| 2018 | 1.57 |
| 2017 | - |
| 2016 | - |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
